Product
RIST4721
3 clinical trials
3 indications
Indication
Hidradenitis SuppurativaIndication
Familial Mediterranean FeverIndication
Palmoplantar PustulosisClinical trial
A Randomized, Double-blinded, Placebo-controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects With Hidradenitis SuppurativaStatus: Terminated, Estimated PCD: 2023-02-28
Clinical trial
An Open-label, Single-arm, Phase 2 Study to Evaluate the Safety and Efficacy of RIST4721 in Subjects With Familial Mediterranean FeverStatus: Withdrawn, Estimated PCD: 2023-11-30
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Dose Ranging Phase 2 Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects With Palmoplantar PustulosisStatus: Terminated, Estimated PCD: 2023-02-13